{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:08:58Z","timestamp":1779275338351,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11845-025-04245-3","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:50:46Z","timestamp":1769755846000},"page":"729-736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Glycaemic benefits of smart insulin pens in socioeconomically deprived individuals: a single-Centre study"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1340-0534","authenticated-orcid":false,"given":"Aoife","family":"Courtney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saidhbh","family":"Comerford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"9","key":"4245_CR1","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2337\/dc23-0495","volume":"46","author":"KE Karakus","year":"2023","unstructured":"Karakus KE, Akturk HK, Alonso GT, Snell-Bergeon JK, Shah VN (2023) Association between diabetes technology use and glycemic outcomes in adults with type 1 diabetes over a decade. Diabetes Care 46(9):1646\u20131651. https:\/\/doi.org\/10.2337\/dc23-0495","journal-title":"Diabetes Care"},{"key":"4245_CR2","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14906","author":"C Fallon","year":"2022","unstructured":"Fallon C, Jones E, Oliver N, Reddy M, Avari P (2022) The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes. Diabet Med. https:\/\/doi.org\/10.1111\/dme.14906","journal-title":"Diabet Med"},{"issue":"1","key":"4245_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/dia.2020.0112","volume":"23","author":"L Meunier","year":"2021","unstructured":"Meunier L et al (2021) Age, male gender, and social deprivation are associated with a lower rate of insulin pump therapy initiation in adults with type 1 diabetes: a population-based study. Diabetes Technol Ther 23(1):8\u201319. https:\/\/doi.org\/10.1089\/dia.2020.0112","journal-title":"Diabetes Technol Ther"},{"key":"4245_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae210","author":"RB Conway","year":"2024","unstructured":"Conway RB et al (2024) Disparities in diabetes technology uptake in youth and young adults with type 1 diabetes: a global perspective. J Endocr Soc. https:\/\/doi.org\/10.1210\/jendso\/bvae210","journal-title":"J Endocr Soc"},{"key":"4245_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14445","author":"AR Dover","year":"2021","unstructured":"Dover AR et al (2021) Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes. Diabet Med. https:\/\/doi.org\/10.1111\/dme.14445","journal-title":"Diabet Med"},{"issue":"3","key":"4245_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/dme.13833","volume":"36","author":"AN Paisley","year":"2019","unstructured":"Paisley AN et al (2019) Impact of social deprivation, demographics and centre on HbA1c outcomes with continuous subcutaneous insulin infusion. Diabet Med 36(3):383\u2013387. https:\/\/doi.org\/10.1111\/dme.13833","journal-title":"Diabet Med"},{"key":"4245_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/20420188241236289","author":"RA Been","year":"2024","unstructured":"Been RA et al (2024) The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review. Ther Adv Endocrinol Metab. https:\/\/doi.org\/10.1177\/20420188241236289","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"4245_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12939-019-1061-8","volume":"18","author":"A Scott","year":"2019","unstructured":"Scott A, O\u2019Cathain A, Goyder E (2019) Socioeconomic disparities in access to intensive insulin regimens for adults with type 1 diabetes: a qualitative study of patient and healthcare professional perspectives. Int J Equity Health 18(1):150. https:\/\/doi.org\/10.1186\/s12939-019-1061-8","journal-title":"Int J Equity Health"},{"issue":"1","key":"4245_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/S12889-025-23022-6","volume":"25","author":"G Valentelyte","year":"2025","unstructured":"Valentelyte G et al (2025) Socioeconomic disparities in diabetes prevalence among the population in Ireland. BMC Public Health 25(1):2206. https:\/\/doi.org\/10.1186\/S12889-025-23022-6","journal-title":"BMC Public Health"},{"issue":"1","key":"4245_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/S12902-020-00573-W","volume":"20","author":"KA Gajewska","year":"2020","unstructured":"Gajewska KA, Bennett K, Biesma R, Sreenan S (2020) Low uptake of continuous subcutaneous insulin infusion therapy in people with type 1 diabetes in Ireland: a retrospective cross-sectional study. BMC Endocr Disord 20(1):92. https:\/\/doi.org\/10.1186\/S12902-020-00573-W","journal-title":"BMC Endocr Disord"},{"issue":"Supplement_1","key":"4245_CR11","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.2337\/dc24-S007","volume":"47","author":"NA ElSayed","year":"2024","unstructured":"ElSayed NA et al (2024) American Diabetes Association professional practice committee; 7. Diabetes technology: standards of Care in Diabetes\u20142024. Diabetes Care 47(Supplement_1):S126\u2013S144. https:\/\/doi.org\/10.2337\/dc24-S007","journal-title":"Diabetes Care"},{"issue":"4","key":"4245_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2337\/cd24-0057","volume":"42","author":"JG Friedman","year":"2024","unstructured":"Friedman JG, Odugbesan O, Ebekozien O, Aleppo G (2024) Increasing access to connected insulin pens by promoting shared decision-making through collaborative quality improvement. Clin Diabetes 42(4):470\u2013473. https:\/\/doi.org\/10.2337\/cd24-0057","journal-title":"Clin Diabetes"},{"issue":"3","key":"4245_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.18553\/jmcp.2023.22283","volume":"29","author":"A Chien","year":"2023","unstructured":"Chien A et al (2023) Potential cost savings in the United States from a reduction in sensor-detected severe hypoglycemia among users of the InPen smart insulin pen system. J Manag Care Spec Pharm 29(3):285\u2013292. https:\/\/doi.org\/10.18553\/jmcp.2023.22283","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"4245_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1089\/dia.2023.0365","volume":"26","author":"J MacLeod","year":"2024","unstructured":"MacLeod J, Im GH, Smith M, Vigersky RA (2024) Shining the spotlight on multiple daily insulin therapy: real-world evidence of the InPen smart insulin pen. Diabetes Technol Ther 26(1):33\u201339. https:\/\/doi.org\/10.1089\/dia.2023.0365","journal-title":"Diabetes Technol Ther"},{"key":"4245_CR15","unstructured":"Compass Informatics 2022 Pobal HP deprivation index. Pobal"},{"issue":"1","key":"4245_CR16","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","volume":"11","author":"T Battelino","year":"2023","unstructured":"Battelino T et al (2023) Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol 11(1):42\u201357. https:\/\/doi.org\/10.1016\/S2213-8587(22)00319-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"4245_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0177210","volume":"12","author":"A Scott","year":"2017","unstructured":"Scott A, Chambers D, Goyder E, O\u2019Cathain A (2017) Socioeconomic inequalities in mortality, morbidity and diabetes management for adults with type 1 diabetes: a systematic review. PLoS One 12(5):e0177210. https:\/\/doi.org\/10.1371\/journal.pone.0177210","journal-title":"PLoS One"},{"issue":"5","key":"4245_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1177\/1932296821995810","volume":"15","author":"KL Fantasia","year":"2021","unstructured":"Fantasia KL, Wirunsawanya K, Lee C, Rizo I (2021) Racial disparities in diabetes technology use and outcomes in type 1 diabetes in a safety-net hospital. J Diabetes Sci Technol 15(5):1010. https:\/\/doi.org\/10.1177\/1932296821995810","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"4245_CR19","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/DME.14223","volume":"37","author":"JA McKnight","year":"2020","unstructured":"McKnight JA et al (2020) The effect of DAFNE education, continuous subcutaneous insulin infusion, or both in a population with type 1 diabetes in Scotland. Diabet Med 37(6):1016\u20131022. https:\/\/doi.org\/10.1111\/DME.14223","journal-title":"Diabet Med"},{"issue":"6","key":"4245_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/dme.13333","volume":"34","author":"SM Harris","year":"2017","unstructured":"Harris SM et al (2017) Factors influencing attendance at structured education for type 1 diabetes in South London. Diabet Med 34(6):828\u2013833. https:\/\/doi.org\/10.1111\/dme.13333","journal-title":"Diabet Med"},{"issue":"1","key":"4245_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-13-85","volume":"13","author":"K Cauch-Dudek","year":"2013","unstructured":"Cauch-Dudek K, Victor JC, Sigmond M, Shah BR (2013) Disparities in attendance at diabetes self-management education programs after diagnosis in Ontario, Canada: a cohort study. BMC Public Health 13(1):85. https:\/\/doi.org\/10.1186\/1471-2458-13-85","journal-title":"BMC Public Health"},{"issue":"10","key":"4245_CR22","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s001250051043","volume":"41","author":"I M\u00fchlhauser","year":"1998","unstructured":"M\u00fchlhauser I et al (1998) Social status and the quality of care for adult people with type I (insulin-dependent) diabetes mellitus - a population-based study. Diabetologia 41(10):1139\u20131150. https:\/\/doi.org\/10.1007\/s001250051043","journal-title":"Diabetologia"},{"issue":"10","key":"4245_CR23","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/dia.2019.0411","volume":"22","author":"P Adolfsson","year":"2020","unstructured":"Adolfsson P, Hartvig NV, Kaas A, M\u00f8ller JB, Hellman J (2020) Increased time in range and fewer missed bolus injections after introduction of a smart connected insulin pen. Diabetes Technol Ther 22(10):709\u2013718. https:\/\/doi.org\/10.1089\/dia.2019.0411","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"4245_CR24","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/1753-0407.13454","volume":"15","author":"P Natale","year":"2023","unstructured":"Natale P et al (2023) Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: a systematic review of qualitative studies. J Diabetes 15(12):1048. https:\/\/doi.org\/10.1111\/1753-0407.13454","journal-title":"J Diabetes"},{"key":"4245_CR25","doi-asserted-by":"publisher","unstructured":"Tanenbaum ML, Commissariat PV (2023) Experience with burdens of diabetes device use that affect uptake and optimal use in people with type 1 diabetes. Endocr Connect 12(10). https:\/\/doi.org\/10.1530\/EC-23-0193","DOI":"10.1530\/EC-23-0193"},{"issue":"4","key":"4245_CR26","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/CD22-0126","volume":"41","author":"BS Baliga","year":"2023","unstructured":"Baliga BS, Tillman JB, Olson B, Vaughan S, Sheikh FN, Malone JK (2023) First real-world experience with bigfoot Unity: a 6-month retrospective analysis. Clin Diabetes 41(4):539. https:\/\/doi.org\/10.2337\/CD22-0126","journal-title":"Clin Diabetes"},{"issue":"1","key":"4245_CR27","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s13300-020-00980-1","volume":"12","author":"J Jendle","year":"2021","unstructured":"Jendle J, Ericsson \u00c5, Gundgaard J, M\u00f8ller JB, Valentine WJ, Hunt B (2021) Smart insulin pens are associated with improved clinical outcomes at lower cost versus standard-of-care treatment of type 1 diabetes in Sweden: a cost-effectiveness analysis. Diabetes Ther 12(1):373\u2013388. https:\/\/doi.org\/10.1007\/s13300-020-00980-1","journal-title":"Diabetes Ther"},{"issue":"2","key":"4245_CR28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/ENDREV\/BNAC022","volume":"44","author":"M Phillip","year":"2023","unstructured":"Phillip M et al (2023) Consensus recommendations for the use of automated insulin delivery Technologies in Clinical Practice. Endocr Rev 44(2):254\u2013280. https:\/\/doi.org\/10.1210\/ENDREV\/BNAC022","journal-title":"Endocr Rev"},{"key":"4245_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/MDER.S312858","volume":"14","author":"ME Pauley","year":"2021","unstructured":"Pauley ME, Berget C, Messer L, Forlenza G (2021) Barriers to uptake of insulin technologies and novel solutions. Med Devices Evid Res 14:339\u2013354. https:\/\/doi.org\/10.2147\/MDER.S312858","journal-title":"Med Devices Evid Res"},{"issue":"6","key":"4245_CR30","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/dia.2016.0375","volume":"19","author":"PV Commissariat","year":"2017","unstructured":"Commissariat PV et al (2017) Insulin pump use in young children with type 1 diabetes: sociodemographic factors and parent-reported barriers. Diabetes Technol Ther 19(6):363\u2013369. https:\/\/doi.org\/10.1089\/dia.2016.0375","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"4245_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2337\/cd22-0068","volume":"41","author":"E Ospelt","year":"2023","unstructured":"Ospelt E et al (2023) Facilitators and barriers to smart insulin pen use: a mixed-method study of multidisciplinary stakeholders from diabetes teams in the United States. Clin Diabetes 41(1):56\u201367. https:\/\/doi.org\/10.2337\/cd22-0068","journal-title":"Clin Diabetes"},{"issue":"5","key":"4245_CR32","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1007\/s12325-023-02478-1","volume":"40","author":"I Cranston","year":"2023","unstructured":"Cranston I, Jamdade V, Liao B, Newson RS (2023) Clinical, economic, and patient-reported benefits of connected insulin pen systems: a systematic literature review. Adv Ther 40(5):2015\u20132037. https:\/\/doi.org\/10.1007\/s12325-023-02478-1","journal-title":"Adv Ther"},{"issue":"4","key":"4245_CR33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.clinthera.2017.02.008","volume":"39","author":"JA Overbeek","year":"2017","unstructured":"Overbeek JA et al (2017) Type 2 diabetes mellitus treatment patterns across Europe: a population-based multi-database study. Clin Ther 39(4):759\u2013770. https:\/\/doi.org\/10.1016\/j.clinthera.2017.02.008","journal-title":"Clin Ther"},{"key":"4245_CR34","doi-asserted-by":"publisher","DOI":"10.57264\/cer-2023-0124","author":"K Chan","year":"2024","unstructured":"Chan K, Hansen K, Muratov S, Khoudigian S, Lamotte M (2024) Smart connected insulin dose monitoring technologies versus standard of care: a Canadian cost\u2013effectiveness analysis. J Comp Eff Res. https:\/\/doi.org\/10.57264\/cer-2023-0124","journal-title":"J Comp Eff Res"},{"issue":"11\u201312","key":"4245_CR35","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s13300-022-01325-w","volume":"13","author":"R Ajjan","year":"2022","unstructured":"Ajjan R, Bilir SP, Hellmund R, Souto D (2022) Cost-effectiveness analysis of flash glucose monitoring system for people with type 2 diabetes receiving intensive insulin treatment. Diabetes Ther 13(11\u201312):1933\u20131945. https:\/\/doi.org\/10.1007\/s13300-022-01325-w","journal-title":"Diabetes Ther"},{"issue":"6","key":"4245_CR36","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2337\/dc23-2176","volume":"47","author":"TPA Danne","year":"2024","unstructured":"Danne TPA, Joubert M, Hartvig NV, Kaas A, Knudsen NN, Mader JK (2024) Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting. Diabetes Care 47(6):995\u20131003. https:\/\/doi.org\/10.2337\/dc23-2176","journal-title":"Diabetes Care"},{"issue":"3","key":"4245_CR37","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1177\/19322968211062624","volume":"16","author":"DT Ahn","year":"2022","unstructured":"Ahn DT (2022) Automated bolus calculators and connected insulin pens: a smart combination for multiple daily injection insulin therapy. J Diabetes Sci Technol 16(3):605\u2013609. https:\/\/doi.org\/10.1177\/19322968211062624","journal-title":"J Diabetes Sci Technol"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-025-04245-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-025-04245-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:41:00Z","timestamp":1779273660000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-025-04245-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4245"],"URL":"https:\/\/doi.org\/10.1007\/s11845-025-04245-3","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Quality, Safety and Improvement Directorate at St James\u2019s Hospital (no 181).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}